Friday, 14 March 2025
SciBase Holding Ab a leading developer of augmented intelligence-based solutions for skin disorders announced, that an article comparing US and German dermatologists improved biopsy decisions following the addition of Nevisense (EIS) as a decision support tool was recently published in SKIN, the Journal of Cutaneous Medicine. The article compares two corresponding studies, one
SciBase Holding AB, a leading developer of augmented intelligence-based solutions for skin disorders announced , that an article comparing US and German dermatologists improved biopsy decisions following the addition of Nevisense (EIS) as a decision support tool was recently published in SKIN, the Journal of Cutaneous Medicine. The article compares two corresponding studies, one con
By subscribing, you agree to receive email related to content and products. You unsubscribe at any time.
Copyright 2025, AI Reporter America All rights reserved.
